Hsp90-Cdc37-IN-2
Hsp90-Cdc37-IN-2 (Compound 41) is an inhibitor for the interaction between heat shock protein 90 (Hsp90) and cyclin 37 (Cdc37) . Hsp90-Cdc37-IN-2 inhibits the proliferation of cancer cell A549, MCF-7, HOS and HepG2 with IC50 of 0.41-0.94 μM. Hsp90-Cdc37-IN-2 decreases the mitochondrial membrane potential, induces apoptosis, and arrest cell cycle at G0/G1 phase in A549[1].
Product Specifications
CAS Number
2413849-81-5
UNSPSC
12352005
Target
Apoptosis; HSP
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsp90-cdc37-in-2.html
Smiles
C[C@@]12[C@]([C@@]3([H])[C@@](CC1)(CC[C@](C)(C3)C(OCCCOC(/C=C(C4=CC=C(C=C4)F)\C#N)=O)=O)C)(CC[C@@]5(C2=CC=C6C5=CC(C(O)=C6C)=O)C)C
Molecular Formula
C42H48FNO6
Molecular Weight
681.83
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/1994R), 0.2mg/mL
(Z)-tert-Butyl 3-(2-Ethoxy-2-oxoethylidene)-4-oxopiperidine-1-carboxylate
![FOXL2 Recombinant Rabbit Monoclonal Antibody [JE38-52]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81aba/imageurl/ha721558.webp)